Weight is not just about appearance. It affects your heart, joints, hormones, sleep and long-term health. Our doctor-led programmes are built to treat the biology behind weight gain, not just the symptoms.
At Nexus Clinic Kuala Lumpur, every programme is supervised by licensed doctors who review your medical history, assess the root causes of weight gain, and build a plan based on your body, your risk profile and your lifestyle.
Important Clinical Note
Programmes available: GLP-1, Duromine, HCG, Wegovy, Ozempic, Mounjaro — All medically supervised at Nexus Clinic KL.
Programmes available:
GLP-1, Duromine, HCG, Wegovy, Ozempic, Mounjaro
Doctor Monitored Weight Loss
None. Fully non-invasive options available
0.5 to 1.5 kg per week depending on protocol
Weekly or fortnightly check-ins
BMI above 25, obesity-related conditions, failed previous attempts
GLP-1 agonists, Duromine, HCG, Mounjaro, Wegovy, Ozempic
Bariatric referral for eligible BMI 35+ patients
Complimentary consultation
Modern obesity medicine recognises that weight gain is not a personal failure. It is driven by hormonal, metabolic, neurological, structural and behavioural factors that often require medical intervention to correct.
This is why diet and exercise alone often fail without medical support. Repeated caloric restriction can slow metabolism, increase hunger and encourage rebound weight gain. Doctor-led weight loss works by treating the physiology behind the pattern.
Supervision by an experienced healthcare professional is not optional when these risk factors are present. It is essential. Self-managed weight loss in patients with hypertension, fatty liver, or metabolic syndrome carries real clinical risk if medications are adjusted or caloric restriction is too severe without monitoring. The structured blood tests, vital sign checks, and ongoing doctor oversight built into every programme at Nexus Clinic KL ensure safety at every stage. CoolSculpting in Malaysia to address localised fat deposits that do not respond to weight loss alone.
At Nexus Clinic KL, the programme is matched to the causes driving your weight gain, not simply to the number on the scale.
Thyroid issues, PCOS, insulin resistance and cortisol-related fat storage patterns.
Repeated dieting lowers metabolic rate and makes further loss harder.
Leptin and ghrelin dysfunction can drive persistent hunger despite adequate intake.
Joint pain or disability can limit physical activity and worsen weight gain.
Stress, sleep deprivation, emotional eating and Malaysian food culture can all contribute.
Some antidepressants, steroids and diabetes drugs can worsen excess weight.
Not every patient needs the same strategy. The doctor at Nexus Clinic KL matches your programme to your BMI, medical history, risk factors and previous weight-loss experience.
BMI 25 to 29.9: structured lifestyle plus Duromine or HCG programme.
BMI 30 to 34.9: GLP-1 programme like Ozempic or Saxenda with dietary coaching.
BMI 35 to 39.9: Mounjaro or Wegovy plus metabolic workup and meal planning.
BMI 40 and above: intensive GLP-1 protocol or bariatric surgery evaluation.
Protocol switch, dose escalation or selective adjunct body contouring discussion.
Medical supervision, nutrition monitoring and hormonal support where needed.
Obesity increases the risk of type 2 diabetes, hypertension, heart disease, fatty liver disease, sleep apnoea, joint pain and reduced mobility. In these cases, self-directed weight loss is not enough. It needs monitoring.
Patients interested in specific GLP-1 programmes can learn more about Ozempic weight loss in Malaysia, Mounjaro weight loss in Malaysia, and the full GLP-1 programme at Nexus Clinic on the dedicated programme pages.
Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine. 2021;384:989-1002. The STEP 1 trial demonstrated 14.9% mean body weight loss with semaglutide versus 2.4% with placebo, confirming the significant impact of GLP-1 receptor agonism on medically supervised weight reduction.
GLP-1 medications and other prescription tools have transformed medically supervised weight loss in Malaysia. These are used only after consultation and assessment.
GLP-1 weekly injection, diabetes plus weight management
Dual GIP/GLP-1 weekly injection, maximum metabolic impact
Higher-dose semaglutide, obesity-specific indication
Daily GLP-1 injection, often first-time GLP-1 pathway
Daily oral appetite suppressant for shorter-term use
Fast initial metabolic reset structure
For patients with BMI 35 or above, especially with comorbidities like type 2 diabetes, severe hypertension or fatty liver disease, bariatric surgery may be the most clinically appropriate pathway.
Nexus Clinic KL does not perform bariatric surgery directly, but it can provide honest guidance, referral, pre-operative support and post-bariatric maintenance care when surgery is proportionate and necessary.
A 45 to 60 minute consultation covering your weight history, medications, lifestyle and relevant comorbidities.
Baseline testing may include blood count, kidney and liver function, fasting glucose, HbA1c, lipid profile, thyroid panel and selected hormonal markers.
Your doctor builds a written plan covering medication pathway, meal structure, physical activity targets and follow-up schedule before any prescription is issued.
Injection training is provided where needed. Weekly or fortnightly check-ins track weight, side effects, vital signs and progress toward targets.
The programme is adjusted over time based on body composition, metabolic markers, plateaus, side effects and changes in health status.
All programmes at Nexus Clinic KL are supervised by qualified doctors trained in obesity medicine and metabolic health. Blood tests may be repeated during treatment to monitor liver, kidney and metabolic markers. Blood pressure and pulse are checked regularly.
GLP-1 medications can cause nausea, bloating and loose stools during dose titration. Duromine patients are monitored for heart rate and blood pressure effects. HCG protocol patients are monitored for energy levels and electrolyte balance.
Malaysia-specific safety note: NPRA has published updated safety alerts on GLP-1 medicines, including semaglutide and tirzepatide, concerning aspiration and aspiration pneumonia risk during general anaesthesia or deep sedation. Patients must tell their doctor and anaesthetist if they are taking these medicines before any procedure.
The support you receive at Nexus Clinic KL extends beyond prescriptions. Your doctor provides guidance on building healthy habits that outlast the medication phase. The aim is always to help you maintain your results and avoid the cycle of weight loss followed by rapid regain that plagues unmonitored approaches. hormone test and evaluation in Malaysia to rule out underlying hormonal contributors to weight difficulty.
Weight loss is usually gradual. The right programme aims for steady, sustainable progress rather than short-term extremes.
In the STEP 1 trial, once-weekly semaglutide with lifestyle support produced an average weight loss of 14.9% versus 2.4% with placebo. Real-world results still vary by protocol, adherence, starting weight and metabolic profile.
Factors that shape your outcome:
Best for overall fat loss, appetite control, metabolic health and long-term maintenance.
Best for stubborn fat pockets and shape refinement, not for large overall weight reduction.
Best for severe obesity and more complex medical risk profiles, under specialist care.
A doctor monitored programme, not a beauty-salon slimming package
Clear steps from consultation to maintenance
Multiple evidence-based options under one medical team
Honest advice if a programme is not right for you
Accessible KL location at Wisma UOA II, Jalan Pinang
The cost of a medically supervised weight loss programme at Nexus Clinic KL depends on the protocol chosen, the medications prescribed, and the duration of your programme. All first consultations are complimentary. Blood tests and medications are priced transparently and itemised on your treatment plan before you commit. There are no hidden package fees. The table below reflects updated 2026 pricing as a reference. Patients combining weight loss programmes with fat freezing in Malaysia for body contouring may qualify for combined programme pricing. Your doctor will discuss all options during consultation.
| Programme | Duration | Price |
|---|---|---|
| Duromine Weight Loss Programme | 1 month supply | RM438 promo / RM1,134 normal |
| HCG Weight Loss Programme | 23 or 40-day cycle | RM2,300–RM4,000 promo |
| Ozempic Programme | Per pen | RM1,800 promo / RM2,500 normal |
| Wegovy Programme | Per pen, depending on dose | RM1,088–RM1,888 |
| Mounjaro Programme | Per pen, listed doses only | RM1,588–RM2,188 |
| Zepbound Programme | Subject to availability | Pricing not confirmed |
| Comprehensive Weight Management | Custom programme | Pricing varies by programme structure |
Programme
Duromine Weight Loss Programme
Duration
1 month supply
Price
RM438 promo / RM1,134 normal
Programme
HCG Weight Loss Programme
Programme
Ozempic Programme
Programme
Wegovy Programme
Programme
Mounjaro Programme
Programme
Zepbound Programme
Programme
Comprehensive Weight Management
A medical weight loss clinic operates under medical licensing with licensed doctors who can prescribe, adjust, and supervise treatment, conduct blood tests, and manage health conditions that complicate weight loss. Commercial slimming centres cannot provide the same clinical supervision.
Diet and exercise still matter, but the programme is designed to be realistic rather than rigid. Nutrition and activity guidance are adapted to Malaysian food culture, lifestyle, and any mobility limitations.
GLP-1 medications are generally considered for adults with BMI 27 or above plus at least one weight-related medical condition, or BMI 30 or above without comorbidities. Full medical consultation and blood tests are required before prescription.
Results vary by starting weight, protocol, adherence and metabolic profile. As a broad guide, Duromine or HCG programmes may produce a few kilograms per month, while GLP-1 programmes and tirzepatide-based programmes can produce much larger percentage reductions over longer timelines.
Nexus Clinic KL does not perform bariatric surgery directly but can provide medically guided preparation, maintenance support, and referral to accredited bariatric specialists in Kuala Lumpur when surgery is the appropriate option.
The initial blood panel may include full blood count, kidney and liver function, fasting glucose, HbA1c, lipid profile, thyroid markers, and selected hormonal markers when clinically indicated.
Yes, but the programme must account for the hormonal driver. Nexus Clinic KL screens for issues like thyroid dysfunction, insulin resistance and PCOS-related metabolic problems before finalising the treatment plan.
The answer depends on the medication and your clinical response. GLP-1 programmes are often longer-term because obesity is a chronic condition and stopping treatment too early can lead to regain without a proper maintenance strategy.
Yes, and in many cases it is especially appropriate because even modest weight loss can improve blood pressure, glucose control and cardiovascular risk. These patients are monitored more closely during active treatment.
The process starts with a complimentary first consultation at Nexus Clinic KL, followed by medical assessment, blood tests when needed, and a personalised plan before treatment begins.
Book your complimentary first consultation at Nexus Clinic Kuala Lumpur and get a personalised medical plan built around your body, your risks and your goals.
Book Free Consultation